Investors / filer profile

Heron Patrick J

active in 4 companies · 3 of 3 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 10
Filings: 4
Companies: 2026-06-05
Last filed

EDGAR · CIK 0001365617 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+63.8%

median move per position

+7.8%

S&P 500 median, same spans

3 of 3

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$21.06M bought

All filings on record

Every Form 4 transaction we track for this filer


ARQTArcutis Biotherapeutics, Inc.	Grant — · 5,778 sh	2026-06-05	—
MIRMMirum Pharmaceuticals, Inc.	Buy $9.00M · 131,425 sh	2026-01-23	—
MIRMMirum Pharmaceuticals, Inc.	Other — · 159,277 sh	2026-01-23	—
MBXMBX Biosciences, Inc.	Buy $12.00M · 666,666 sh	2025-09-26	—
HLVXHilleVax, Inc.	Grant — · 17,199 sh	2025-06-23	—
ARQTArcutis Biotherapeutics, Inc.	Buy $34.6K · 2,646 sh	2025-06-13	—
ARQTArcutis Biotherapeutics, Inc.	Grant — · 7,609 sh	2025-06-12	—
ARQTArcutis Biotherapeutics, Inc.	Buy $5.1K · 378 sh	2025-06-05	—
ARQTArcutis Biotherapeutics, Inc.	Buy $25.2K · 1,890 sh	2025-06-04	—
MIRMMirum Pharmaceuticals, Inc.	Exercise — · 5,703 sh	2025-05-29	—

ARQTGrant

2026-06-05 · Arcutis Biotherapeutics, Inc.

5,778

—

MIRMBuy

2026-01-23 · Mirum Pharmaceuticals, Inc.

$9.00M

—

MIRMOther

2026-01-23 · Mirum Pharmaceuticals, Inc.

159,277

—

MBXBuy

2025-09-26 · MBX Biosciences, Inc.

$12.00M

—

HLVXGrant

2025-06-23 · HilleVax, Inc.

17,199

—

ARQTBuy

2025-06-13 · Arcutis Biotherapeutics, Inc.

$34.6K

—

ARQTGrant

2025-06-12 · Arcutis Biotherapeutics, Inc.

7,609

—

ARQTBuy

2025-06-05 · Arcutis Biotherapeutics, Inc.

$5.1K

—

ARQTBuy

2025-06-04 · Arcutis Biotherapeutics, Inc.

$25.2K

—

MIRMExercise

2025-05-29 · Mirum Pharmaceuticals, Inc.

5,703

—

10 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.